Aug. 1, 2013
/PRNewswire/ --Organovo Holdings, Inc. (NYSE MKT: ONVO) today announced that it intends to offer and sell shares of its common stock in an underwritten public offering. The offering is subject to market conditions, and there can be no assurance as to whether or when the offering may be completed, or as to the actual size or terms of the offering. Organovo also expects to grant the underwriters a 30-day option to purchase up to an additional 15% of the shares of common stock offered in the public offering to cover over-allotments, if any. All of the shares in the offering are to be sold by Organovo.
Lazard Capital Markets LLC and Oppenheimer & Co. Inc. are acting as joint book-runners for the offering.
A shelf registration statement on Form S-3 relating to the public offering of the shares of common stock described above was filed with the Securities and Exchange Commission (SEC) and declared effective by the SEC on
July 26, 2013
. A preliminary prospectus supplement relating to and describing the terms of the offering will be filed with the SEC and will be available on the SEC's web site at
. When available, copies of the preliminary prospectus supplement relating to these securities may also be obtained from the offices of Lazard Capital Markets LLC at 30 Rockefeller Plaza, 60th Floor,
New York, NY
, 10020 or via telephone at (800) 542-0970, or the offices of Oppenheimer & Co. Inc., Attn: Syndicate Department, at 85 Broad Street, 26th Floor,
New York, NY
, 10004 or via email at
or via telephone at (212) 667-8563.
This press release does not constitute an offer to sell or the solicitation of an offer to buy any of these securities, nor will there be any sale of these securities in any state or other jurisdiction in which such offer, solicitation or sale is not permitted.